Los Angeles Biotechnology Network
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Subscribe
  • Contact
News Ticker
  • [ September 24, 2022 ] Research Associate I Per Diem – Riera Lab – Center for Neural Sciences and Medicine – CEDARS-SINAI – Los Angeles, CA Los Angeles Biotech Jobs
  • [ September 24, 2022 ] Project Scientist – Knott Lab – Bioinformatics & Functional Genomics – CEDARS-SINAI – Los Angeles, CA Los Angeles Biotech Jobs
  • [ September 24, 2022 ] Postdoctoral Scientist – Ghiam Lab – Regenerative Medicine Eye Program – CEDARS-SINAI – Los Angeles, CA Los Angeles Biotech Jobs
  • [ September 24, 2022 ] Postdoctoral Scientist – Vujkovic-Cvijin Lab – Immunology – CEDARS-SINAI – Los Angeles, CA Los Angeles Biotech Jobs
  • [ September 24, 2022 ] Field Applications Scientist – Life Sciences – FUJIFILM – Santa Ana, CA Los Angeles Biotech Jobs
HomeLos Angeles Biotech NewsMateon Provides Update on OT-101

Mateon Provides Update on OT-101

June 1, 2020 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Mateon Provides Update on OT-101

AGOURA HILLS, Calif., June 01, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics Inc.  (OTCQB:MATN) report several peer-reviewed publications derived from its R&D effort against COVID-19.

Click to view original post

Previous

ChromaDex to Host Symposium on NAD+ in Human Health and Disease at NUTRITION 2020 LIVE ONLINE Annual Meeting

Next

HemaCare Adds GMPrimeTM Cryopreserved Leukopak to its GMP Product Portfolio

Follow/Subscribe

POST A JOB
Tweets by LABioNetwork

Copyright © 2021 Biotech Networks, LLC

Want to Save Time?

Get Trending News & Jobs Delivered